Autonomix Medical【AMIX】銘柄情報

Autonomix Medical Inc (AMIX) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.3748

( -7.39% )

買値

0.36

売値

0.3744

出来高

107,965

0.3713 日の範囲 0.401

0.2002 52 週間の範囲 2.6399

時価総額

4.276M

前日終値

0.4047

始値

0.401

時刻

1000

0.3748

(formt)

最終取引時間

財務取引量

US$ 42,059

VWAP

0.389558

平均取引量 (3 か月)

US$ 711,005

発行済株式数

11,409,344

配当利回り

PER

-0.18

1 株当たり利益 (EPS)

-2.32

歳入

純利益

-16.72M

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate... Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

autonomix.com

本社

The Woodlands, United States

設立

2026

Autonomix Medical Inc is listed in the Healthcare sector of the ナスダック市場 with ticker AMIX. The last closing price for Autonomix Medical was US$0.40. Over the last year, Autonomix Medical shares have traded in a share price range of US$ 0.2002 to US$ 2.6399.

Autonomix Medical currently has 11,409,344 shares in issue. The market capitalisation of Autonomix Medical is US$4.28 million. Autonomix Medical has a price to earnings ratio (PE ratio) of -0.18.

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology

Access the segment here THE WOODLANDS, TX, June 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical...

Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine

Dr. Toufic Kachaamy Discusses Visceral Cancer Pain Treatment Differentiation, Pancreatic Cancer Feasibility...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation

Technology unlocks minimally invasive transvascular access to nerve targets and tissues through and beyond the...

Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

THE WOODLANDS, TX, May 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or...

Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

THE WOODLANDS, TX, April 29, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or...

Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026

THE WOODLANDS, TX, April 22, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or...

Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026

THE WOODLANDS, TX, April 08, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or...

Form S-8 - Securities to be offered to employees in employee benefit plans

Autonomix Medical to Present at LSI USA ’26

THE WOODLANDS, TX, March 11, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0237	-5.94730238394	0.3985	0.41	0.3672	116543	0.40386227	CS
4	0.0448	13.5757575758	0.33	0.42299	0.2002	2037891	0.30256374	CS
12	-0.0782	-17.2626931567	0.453	0.4699	0.2002	749514	0.31138998	CS
26	-0.4407	-54.0404659718	0.8155	0.8962	0.2002	1978838	0.51317454	CS
52	-1.0852	-74.3287671233	1.46	2.6399	0.2002	2641893	0.99125478	CS
156	-7.2252	-95.0684210526	7.6	21.49	0.2002	1760876	1.50556624	CS
260	-7.2252	-95.0684210526	7.6	21.49	0.2002	1760876	1.50556624	CS

AMIX - Frequently Asked Questions (FAQ)

What is the current Autonomix Medical Inc share price?

The current share price of Autonomix Medical Inc is US$ 0.3748

How many Autonomix Medical Inc shares are in issue?

Autonomix Medical Inc has 11,409,344 shares in issue

What is the market cap of Autonomix Medical Inc?

The market capitalisation of Autonomix Medical Inc is USD 4.28M

What is the 1 year trading range for Autonomix Medical Inc share price?

Autonomix Medical Inc has traded in the range of US$ 0.2002 to US$ 2.6399 during the past year

What is the PE ratio of Autonomix Medical Inc?

The price to earnings ratio of Autonomix Medical Inc is -0.18

What is the registered address of Autonomix Medical Inc?

The registered address for Autonomix Medical Inc is 21 Waterway Avenue, The Woodlands, Texas, 77380

What is the Autonomix Medical Inc website address?

The website address for Autonomix Medical Inc is autonomix.com

Which industry sector does Autonomix Medical Inc operate in?

Autonomix Medical Inc operates in the Medical Equipment & Supplies sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Autonomix Medical Inc (AMIX)

Autonomix Medical Inc (AMIX) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

Autonomix Medical Inc について

AMIX 最新ニュース

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology

Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation

Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026

Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026

Form S-8 - Securities to be offered to employees in employee benefit plans

Autonomix Medical to Present at LSI USA ’26

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology

Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation

Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026

Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026

AMIX - Frequently Asked Questions (FAQ)

AMIX 取引

AMIX Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する